免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ADVIA Centaur 紅血球生成素 (EPO) 測試

K 號:K183088 · 2019-08-02

決定日期2019-08-02
產品代碼GGT
諮詢委員會HE 請提供完整的描述文本,以便我能夠進行翻譯。
決定相當於

器材摘要

ADVIA Centaur Erythropoietin (EPO) assay is the device name listed in this FDA 510(k) record. The listed applicant is Axis-Shield Diagnostics Limited. It received FDA 510(k) clearance on 2019-08-02 under 510(k) number K183088. The device is classified under product code GGT. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ADVIA Centaur Erythropoietin (EPO) assay?

ADVIA Centaur Erythropoietin (EPO) assay is a medical device that received FDA 510(k) clearance on 2019-08-02. The listed applicant is Axis-Shield Diagnostics Limited. The 510(k) number is K183088.

When did ADVIA Centaur Erythropoietin (EPO) assay receive FDA 510(k) clearance?

ADVIA Centaur Erythropoietin (EPO) assay received FDA 510(k) clearance on 2019-08-02, under 510(k) number K183088.

Who is the listed applicant for ADVIA Centaur Erythropoietin (EPO) assay?

The FDA 510(k) record lists Axis-Shield Diagnostics Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVIA Centaur Erythropoietin (EPO) assay?

The FDA product code for ADVIA Centaur Erythropoietin (EPO) assay is GGT.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Axis-Shield Diagnostics Limited 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:GGT)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑